Abstract
Aim:
The aim of this study was to investigate the risk factors for cognitive impairment in older people with diabetes.
Methods:
This cross-sectional study included 2626 community-dwelling participants with diabetes aged ⩾55 years, living in Beijing, China. The participants were screened for risk factors, including smoking, obesity, hypertension, stroke, coronary heart disease, dyslipidemia, depression, apolipoprotein E (APOE) genotype, and low physical activity. Cognitive function was assessed with the scholarship-adjusted Mini-Mental State Examination (MMSE): MMSE ⩽17 for iliterate participants; MMSE ⩽20 for primary school graduates (⩾6 years of education); and MMSE ⩽24 for junior school graduates or above (⩾9 years of education).
Results:
The prevalence of cognitive impairment in older people with diabetes was 9.90%. Multiple logistic regression analysis demonstrated that stroke [odds ratio (OR) = 1.71, 95% confidence interval (CI) = 1.20–2.43], less than 0.5 h exercise per day (OR = 1.89, 95% CI = 1.37–2.61), and depression (OR = 1.64, 95% CI = 1.06–2.54), but not smoking, obesity, hypertension, dyslipidemia, and coronary heart disease, were independent risks for cognitive impairment in older people with diabetes. In addition, being married (OR = 0.66, 95% CI = 0.47–0.93) and urban living (OR = 0.33, 95% CI = 0.22–0.48) could decrease the risk of cognitive impairment.
Conclusions:
Stroke, depression, and less than 0.5 h exercise per day were independent risks for cognitive impairment in older people with diabetes, whereas being married and urban living were protective.
Keywords: cognitive impairment, dementia, diabetes, MMSE, risk factor, stroke
Introduction
Dementia and diabetes are two prevalent conditions affecting older people. Comorbidity is common and with the rapid aging of the population in China, these health issues have become important public health concerns. Previous studies have shown that type 2 diabetes mellitus (T2DM) is associated with cognitive impairment and increased risk of dementia.2,3 Because the treatment for cognitive impairment is limited, it is more important to identify the specific risk factors to delay its onset in older people with diabetes.
The risk factors for cognitive impairment in T2DM include vascular risk factors and relevant vascular diseases (e.g. smoking, hypertension, dyslipidemia, obesity, stroke, coronary heart disease), low physical activity, depression, and the apolipoprotein E (APOE) genotype.1,4 Cardiovascular risks often occur concurrently in the older people, especially in patients with T2DM.5 Thus far, the evidence from previous studies is mixed in supporting the association between cardiovascular risks (e.g. hypertension, hyperlipidemia, and obesity) and cognitive impairment.6–8 Moreover, which cardiovascular risk matters most in people with diabetes is still unidentified. Other studies have shown that low physical activity is correlated with cognitive decline,9 but these results are inconsistent. There is evidence that suggests physical activity may not affect the risk of cognitive decline in people with T2DM.10 Previous studies also showed an inconsistent association between depression and cognitive decline.11,12
To date, investigations into the risk factors for cognitive impairment in people with diabetes have been limited and many risk factors have also been assessed in isolation.13–15 Few studies exploring the association of risk factors for cognitive impairment in people with diabetes have adequately been corrected for all of the confounders. Thus, the aim of this cross-sectional study is to investigate the risk factors for cognitive impairment in a large community-dwelling older population with diabetes.
Participants and methods
Participants
The participants in our study were from the Beijing Longitudinal Study of Aging II (BLSA II) prospective cohort. The baseline survey ran from July to November 2009. A multi-stage cluster random sampling method was performed to select a representative community cohort older than 55 years. Details of recruitment have been described previously.16,17 A total of 10,039 long-term residents from three urban districts and one rural county were enrolled in the survey. Among which, 2626 people with diabetes and a valid Mini-Mental State Examination (MMSE) score were analyzed.
Data collection
All assessments were performed by trained physicians and nurses. Fasting blood samples were taken for measurement of the serum levels of total cholesterol (TCH), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), blood urea nitrogen (BUN), serum creatinine, and serum uric acid (UA) for all subjects. The Sysmex Chemix-180 automatic biochemical analysis device (Sysmex Infosystems, Kobe, Japan) was used to examine blood samples. Fasting blood glucose (FBG) was determined by the One Touch Ultra blood sugar device (Life-Scan, Inc., Milpitas, CA, USA). The APOE genotype was examined using one-stage polymerase chain reaction (PCR) as described by Wenham et al.18
A validated Chinese version of the MMSE was administered to evaluate the cognitive function.19 To assess depression, Geriatric Depression Scale-15 items (GDS-15) were assessed.20
Definitions
As validated in the previous study,19 cognitive impairment was defined as: MMSE ⩽17 for illiterates; MMSE ⩽20 for primary school graduates (⩾6 years of education); MMSE ⩽24 for junior school graduates above (⩾9 years of education).
People with diabetes, as defined by World Health Organization (WHO) criteria,21 are those who are found to have a fasting plasma glucose (FPG) greater than or equal to 7.0 mmol/l (126 mg/dl) or have already been diagnosed with diabetes, or are undergoing antidiabetic therapy. Hyperuricemia was defined as a serum UA level >416 μmol/l in men and >356 μmol/l in women.22
Risk factors include: residency (urban living, rural living); smoking (current smoker); obesity [body mass index (BMI) ⩾28 kg/m2, as defined by Cooperative Meta-analysis Group of China Obesity Task Force criteria];23 hypertension [systolic blood pressure (SBP) ⩾140 mmHg, diastolic blood pressure (DBP) ⩾90 mmHg, having already-diagnosed hypertension or using antihypertensive agents]; dyslipidemia [TCH ⩾6.22 mmol/l or TG ⩾2.26 mmol/l or LDL-C ⩾4.14 mmol/l or HDL-C <1.04 mmol/L]; stroke (a self-reported history of stroke diagnosed by at least a district hospital); coronary heart disease (CHD: a history of myocardial infarction, angina, self-reported CHD or cardiac medications use); depression (a GDS score of 5 or more was used to define subjects as having depressive symptoms); low physical activity (daily exercise <0.5 h); high FBG (⩾7.0 mmol/l).
Statistical analyses
Chi-squared tests were employed to test between-group differences in categorical variables. For all continuous variables, the results were reported as the mean and standard deviation (m ± s.d.) and Student’s t-test was used to compare group differences. The Pearson correlation tests were used to test the correlations among the risk factors for cognitive impairment. Potential risk factors of cognitive impairment were analyzed using multivariate logistic regression analyses to calculate the odds ratios (ORs) and 95% confidence intervals (CIs). Demographic, genetic, and clinical variables including age, sex, residency, marital status, current smoking, alcohol drinking, daily sleep <6 h, daily exercise <0.5 h, APOEε4 carrier, obesity, hypertension, CHD and stroke, GDS >5, high UA, dyslipidemia, and high FBG were included in the multivariate logistic regression model.
The analyses of all data were performed using SAS software, version 9.3 (SAS Institute, Inc., Cary, NC, USA). Statistically significant findings were determined using a two-tailed p value of 0.05.
Results
The correlations among the risk factors for cognitive impairment are presented in Table 1. For example, there were significant correlations between TG and age, BMI, DBP, FBG, TCH, LDL-C and HDL-C (the Pearson correlation coefficients were −0.10, 0.12, 0.04, 0.16, 0.28, −0.35, 0.05, respectively).
Table 1.
The correlations among the risk factors for cognitive impairment.
| Age | Education | BMI | SBP | DBP | FBG | TG | TCH | HDL | LDL | GDS | MMSE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Age (years) | 1.00 | |||||||||||
|
Education
(years) |
−0.20△ | 1.00 | ||||||||||
| BMI (kg/m2) | −0.11△ | −0.03 | 1.00 | |||||||||
| SBP (mmHg) | 0.02 | −0.09△ | 0.06# | 1.00 | ||||||||
| DBP (mmHg) | −0.21△ | −0.07△ | 0.08△ | 0.41△ | 1.00 | |||||||
| FBG (mmol/L) | −0.08△ | −0.11△ | 0.05* | 0.03 | 0.09△ | 1.00 | ||||||
| TG (mmol/L) | −0.10△ | −0.04 | 0.12△ | 0.02 | 0.04* | 0.16△ | 1.00 | |||||
| TCH (mmol/L) | −0.07△ | −0.05* | −0.02 | 0.04 | 0.03 | 0.12△ | 0.28△ | 1.00 | ||||
| HDL (mmol/L) | 0.10△ | 0.02 | −0.18△ | −0.02 | −0.10△ | −0.10△ | −0.35△ | 0.24△ | 1.00 | |||
| LDL (mmol/L) | −0.05# | −0.05* | 0.02 | 0.06# | 0.05# | 0.11△ | 0.05# | 0.87△ | 0.13△ | 1.00 | ||
| GDS score | 0.13△ | −0.04* | −0.001 | 0.02 | −0.08△ | 0.005 | −0.02 | −0.0004 | 0.07△ | −0.004 | 1.00 | |
| MMSE score | −0.24△ | 0.39△ | 0.03 | −0.05* | −0.04* | −0.06# | −0.009 | −0.04 | −0.01 | −0.02 | −0.14△ | 1.00 |
Notes: The Pearson correlation coefficients are presented in the table.
p value <0.05; #p value <0.01; △p value <0.001.
BMI, body mass index; DBP, diastolic blood pressure; FBG, fasting blood glucose; GDS, Geriatric Depression Scale; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MMSE, Mini-Mental State Examination; SBP, systolic blood pressure; TCH, total cholesterol; TG, triglycerides.
The characteristics of the participants according to cognitive function status are presented in Table 2. Of the total 2626 participants involved in the analyses, 260 of the participants were classified as having cognitive impairment. The mean cognitive function MMSE score was 26.58 ± 4.11. The prevalence of cognitive impairment was 9.90%. The average age was 71.21 ± 7.41 years, 973 (37.05%) were males.
Table 2.
Characteristics of the participants according to cognitive function status.
| Characteristics | Total sample |
Cognitive impairment | Normal cognitive function | p-value |
|---|---|---|---|---|
| n, (%) | 2626 | 260 (9.90) | 2366 (90.10) | / |
| MMSE score | 26.58 ± 4.11 | 19.29 ± 4.39 | 27.47 ± 2.78 | <0.001 |
| Sociodemographic | ||||
| Age | 71.21 ± 7.41 | 73.51+7.14 | 70.93+7.47 | <0.0001 |
| 55–65, n (%) | 627 (23.87) | 37 (14.23) | 590 (24.94) | <0.0001 |
| 65–75, n (%) | 1140 (43.41) | 114 (43.85) | 1026 (43.36) | / |
| 75–85, n (%) | 808 (30.77) | 94 (36.15) | 714 (30.18) | / |
| ⩾85, n (%) | 51 (1.94) | 15 (5.77) | 36 (1.52) | / |
| Male, n (%) | 973 (37.05) | 89 (34.23) | 884 (37.36) | 0.32 |
| Urban, n (%) | 2167 (82.52) | 196 (75.38) | 1971 (92.56) | 0.0014 |
| Education, n (%) | ||||
| Illiteracy | 298 (11.35) | 31 (11.92) | 267 (11.28) | 0.61 |
| Primary school graduates | 767 (29.21) | 69 (26.54) | 698 (29.50) | / |
| Junior school graduates or above | 1561 (59.44) | 160 (61.54) | 1401 (59.22) | / |
| Lifestyle, n (%) | ||||
| Currently married | 2078 (79.13) | 187 (71.92) | 1891 (79.92) | 0.0026 |
| Alcohol use | 220 (8.38) | 19 (7.31) | 201 (8.5) | 0.51 |
| Smoking, current | 285 (10.85) | 33 (12.69) | 252 (10.65) | 0.31 |
| Sleep <6 h | 467 (17.81) | 63 (24.23) | 404 (17.10) | 0.0044 |
| Physical activity | ||||
| Exercise <0.5 h, n (%) | 614 (23.42) | 90 (34.62) | 524 (22.18) | <0.001 |
| Genetic | ||||
| APOEε4 carrier, n (%) | 213 (10.12) | 26 (13.32) | 187 (9.87) | 0.26 |
| Clinical | ||||
| BMI (kg/m2) | 25.25 ± 3.35 | 25.24+3.43 | 25.26+3.34 | 0.72 |
| BMI ⩾28 kg/m2 | 506 (19.36) | 52 (20.16) | 454 (19.28)) | 0.73 |
| High UA, n (%) | 459 (17.68) | 43 (16.67) | 416 (17.80) | 0.65 |
| Hypertension, n (%) | 1832 (69.90) | 197 (75.77) | 1635 (69.25) | 0.03 |
| CHD*, n (%) | 668 (25.48) | 76 (29.23) | 592 (25.06) | 0.14 |
| Stroke, n (%) | 360 (17.73) | 61 (23.46) | 299 (12.66) | <0.001 |
| GDS>5, n (%) | 285 (11.70) | 46 (18.25) | 239 (10.94) | 0.0006 |
| TCH (mmol/l) | 5.36 ± 1.11 | 5.31 ± 1.11 | 5.36 ± 1.10 | 0.50 |
| TG (mmol/l) | 1.73 ± 1.12 | 1.63 ± 0.80 | 1.74 ± 1.14 | 0.06 |
| HDL-C (mmol/l) | 1.31 ± 0.35 | 1.35 ± 0.54 | 1.30 ± 0.33 | 0.22 |
| LDL-C (mmol/l) | 3.280 ± 0.89 | 3.28 ± 0.92 | 3.28 ± 0.88 | 0.98 |
| FBG (mmol/l) | 8.08 ± 2.66 | 8.31 ± 3.02 | 8.05 ± 2.61 | 0.01 |
| SBP (mmHg) | 129.51 ± 12.58 | 131.7 ± 16.49 | 129.3 ± 12.04 | 0.02 |
| DBP (mmHg) | 77.66 ± 8.10 | 79.05 ± 9.79 | 77.50 ± 7.88 | 0.01 |
APOEε4, apolipoprotein E ε4; BMI, body mass index; DBP, diastolic blood pressure; FBG, fasting blood glucose; GDS, Geriatric Depression Scale; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MMSE, Mini-Mental State Examination; SBP, systolic blood pressure; TCH, total cholesterol; TG, triglycerides; UA, uric acid.
Myocardial infarction, coronary heart disease (CHD), or angina.
Compared with subjects with normal cognitive function, participants with cognitive impairment were older, more likely to have less sleep and exercise, and to have hypertension, stroke, and depression. Participants with normal cognition were more likely to be married, live in an urban area than their counterparts with cognitive impairment. In addition, the SBP, DBP, and serum level of FBG were higher in participants who had cognitive impairment.
Multivariate logistic regression analysis found that daily exercise <0.5 h (OR = 1.89, 95% CI = 1.37–2.61), stroke (OR = 1.71, 95% CI = 1.20–2.43), and GDS >5 (OR = 1.64, 95% CI = 1.06–2.54) were independent risk factors for cognitive impairment. However, urban living (OR = 0.33, 95% CI = 0.22–0.48) and being married (OR = 0.66, 95% CI = 0.47–0.93) were associated with lower prevalence of cognitive impairment (Table 3). Smoking, obesity, hypertension, dyslipidemia, and CHD were not independently associated with cognitive impairment in older people with diabetes in the multivariate model.
Table 3.
Multivariable logistic regression analysis of cognitive impairment in participants with diabetes.
| β | SE | χ2 | Adj. OR | 95% CI | p value | |
|---|---|---|---|---|---|---|
| Urban | −0.56 | 0.10 | 33.42 | 0.33 | 0.22–0.48 | <.0001 |
| Currently married | −0.21 | 0.09 | 5.65 | 0.66 | 0.47–0.93 | 0.02 |
| Exercise <0.5 h | 0.32 | 0.08 | 14.91 | 1.89 | 1.37–2.61 | 0.0001 |
| Stroke | 0.27 | 0.09 | 8.70 | 1.71 | 1.20–2.43 | 0.003 |
| GDS >5 | 0.25 | 0.11 | 4.97 | 1.64 | 1.06–2.54 | 0.03 |
Notes: Analyses included the following covariates: age, gender, location, daily sleep <6 h, daily exercise <0.5 h, marital status, high UA, BMI ⩾28 kg/m2, alcohol drinking, smoking, APOE ε4 carrier, hypertension, stroke, GDS >5, cardiovascular disease, high TCH, high TG, high LDL-C, low HDL-C, high FBG.
BMI, body mass index; CI, confidence interval; FBG, fasting blood glucose; GDS, Geriatric Depression Scale; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; OR, odds ratio; TCH, total cholesterol; TG, triglycerides; UA, uric acid.
Discussion
In the large sample of community-dwelling older people with diabetes, this study showed that univariate predictors of cognitive impairment included age, less sleep and exercise, hypertension, stroke, depression, being married, and urban living. With multiple logistic regression controlling for age, education, sex, apolipoprotein E (APOE) ε4 and other risk factors, stroke, depression, and low physical activity increased the risk of cognitive impairment by 71%, 64%, and 89%, respectively, while being married and urban living reduced the risk of cognitive impairment by 34% and 67%, respectively.
An association between a lower level of cognitive function and stroke has been found in some studies in people with diabetes,24,25 but there are several other analyses in which no such association is found.14 A review also showed that the evidence for a relationship between macro-vascular disease and cognitive decline in diabetes was inconsistent.4 The result of our study is similar to the Edinburgh Type 2 Diabetes Study (ET2DS) which reported that cognitive decline was significantly associated with stroke, but not with nonstroke vascular events.13 Evidence for an association with stroke is stronger than that for vascular sites which are more distant from the brain.4 Stroke may be a surrogate marker for clinically significant atherosclerosis. It is speculated that an increased risk of cognitive impairment in older people with diabetes is probably contingent on many processes, such as white matter integrity, vascular lesions, and Alzheimer-type abnormalities.1 Thus, interventions designed to reduce the incidence of stroke may also be effective in reducing the risk of cognitive impairment.
The association between depressive symptoms and diabetes-associated cognitive impairment was inconsistent.12,26 A national population-based cohort study showed that depression and diabetes were independently associated with a greater risk for dementia, and the combined association of both exposures with the risk for dementia was stronger than the additive association.11 Our study demonstrated that depression was associated with an increased risk for cognitive impairment. However, it is not known whether depression leads to cognitive impairment or vice versa.27 A prospective population based study showed that depression seems to be a concomitant symptom of cognitive impairment rather than an independent risk factor.28 Therefore, caregivers should pay more attention to early detection and treatment of depression in older people with cognitive impairment.
The evidence form previous studies is inconsistent in supporting the effects of exercise on cognitive function.9,10,29,30 Our study showed that low physical activity was related to an increased risk of cognitive impairment in the multivariate analysis. Exercise-mediated physiologic mechanisms, which likely account for neuroprotective effects on brain structures, include facilitation of synaptogenesis, reduced disordered protein deposition, and improved vascularization.30 In addition, exercise may mediate cardiovascular risk factors that are associated with cognitive decline, such as hypertension, dyslipidemia, and obesity. However, the causal relationship between physical activity and cognitive impairment is not clear. Sabia et al.31 reported that physical activity in people with dementia began to decline up to 9 years before diagnosis. Previous findings showing a lower risk of dementia in physically active people may be due to a decline in physical activity levels in the preclinical phase of dementia. The cross-sectional design of this study precludes determination of cause and effect between low physical activity and cognitive impairment. Thus, further prospective studies are needed to identify the most beneficial aspects of exercise programs.
Although hypertension causes stroke, its role in cognitive impairment remains unproven.32 Kennelly et al.33 suggest the ‘U-phenomenon’ to characterize the relationship between blood pressure and dementia. A Cochrane review shows that blood pressure lowering in later life does not appear to prevent the development of dementia or cognitive impairment in hypertensive patients without prior cerebrovascular disease.34 We found that participants with cognitive impairment were more likely to be affected by hypertension in the univariate analysis, but hypertension was not a risk factor for cognitive impairment after adjusting for other risk factors. The association between hypertension and cognitive function is complex, and further studies are warranted to explore hypertension management strategies for older people. The association between obesity and cognitive impairment is inconsistent. A meta-analyses showed that underweight, overweight, and obesity in midlife increase dementia risk.35 However, other studies reported no association between BMI and cognitive impairment in older people with diabetes.14,25 A recent prospective study showed that weight loss in later life characterized dementia, suggesting that obesity is a protective factor against dementia in older age.36 The present study found no association between obesity and cognitive impairment. Hence, further studies are needed to clarify the association between obesity and the risk of cognitive impairment in older people with diabetes.
Our study suggests that CHD is not associated with cognitive impairment. The results have been negative in most cross-sectional studies25,32 and in all prospective analyses.13,14 The role of dyslipidemia in cognitive impairment in people with diabetes is also uncertain. Most studies failed to find any association between plasma lipid profiles and cognitive function.37,38 A few studies reported that elevated levels of plasma TG, cholesterol39 or lower mean HDL-C8 were associated with poorer cognitive function. However, these small studies have not adequately been corrected for all of the confounding risk factors. The most recent longitudinal study40 and meta-analysis showed that smoking is associated with increased risk of dementia.41 A recent large cohort study showed smoking cessation was associated with decreased risk of dementia.42 Our study found no association between smoking and cognitive impairment. These conflicting results may be due to the different study populations examined and different study designs used.
The influence of socio-demographic and genetic factors on cognitive impairment has been investigated in several studies. Our study showed that being married and urban living were protective factors in the multivariate analysis. These results are consistent with previous studies.17,43 A population-based study of dementia progression demonstrating that the slower rates of cognitive and functional decline in those with Alzheimer’s dementia who have spouse caregivers suggest a particular importance of marital relationships in dementia care.44 Living with a spouse meant more interactions and communications. Positive spousal interactions and high caregiver commitment were associated with delayed nursing home placement in dementia.45 Consistent with previous studies, our study showed the prevalence of cognitive impairment was higher in rural areas than in urban ones. Low education level and low socioeconomic status in the rural population might be important reasons for the urban–rural differences.46,47 Some studies in the general population have shown that APOE ε4 carrier status is a risk factor for dementia. However, studies in people with diabetes suggest an uncertain association between APOE ε4 carrier status and risk of cognitive impairment.14,15,49 Our study found an increased trend for the percentage of APOE ε4 carrier status in people with cognitive impairment compared with people with normal cognition. (13.32% versus 9.87%, p = 0.26). Our logistic regression model showed that APOE ε4 carrier status was not an independent risk factor for cognitive impairment, possibly due to lack of statistical power or the inclusion of different study populations.
The strength of this study is its population-based design with a large diabetic population size. Moreover, almost all important risk factors were covered in the present study. The risk factors for cognitive impairment, such as demographics, low physical activity, laboratory data, relevant diseases, and genetic vulnerability (APOE ε4 allele) were also considered in assessing the relations between risk factors and cognitive impairment. There are a few limitations in this study. First, because this is a cross-sectional study, whether risk factors are the cause or consequence of cognitive impairment cannot be definitely determined. Second, MMSE tests were used to define cognitive impairment, which may miss out mild cognitive impairment owing to its low sensitivity, although MMSE tests are still the most commonly used tests for cognitive screening in a population study. Third, medications that potentially affect cognitive function were not included in the study. Fourth, in multiple logistic regression analyses, entering all risk factors into a single model is not always the best approach to analyzing the data. However, entering highly correlated variables into the same multivariate model can result in predictors being eliminated in the process. Thus, further well-designed prospective studies are needed to clarify the correlation between risk factors and cognitive decline in people with diabetes.
Conclusion
In this large sample of older people with diabetes, stroke, depression, and low physical activity were all independent risk factors for cognitive impairment. Prevention of stroke, early detection and treatment of depression, and more exercise are crucial to reducing the risk of cognitive impairment in older people with diabetes.
Acknowledgments
The authors thank all BLSA II study personnel and participants for their great contributions to the study.
Footnotes
Authors’ note: Study design and manuscript preparation: PC, SX acquisition of subjects and data: SX, QL, LS; analysis and interpretation: SX, QL, LS funding and critical review: PC; final version manuscript preparation and approval: all authors.
Funding: This work was funded by the Beijing Municipal Administration of Hospitals’ Mission Plan (Grant Number SML20150803), Beijing Municipal Science and Technology Commission (Grant Numbers Z161100000216140 and Z171100000117013), and the The National Key R&D Program of China (Grant Numbers 2018YFC1312000 and 2017YFC0840105).
Conflict of interest statement: The authors declare that there is no conflict of interest.
Ethics approval and informed consent: The study received ethical approval from the Research Ethics Boards at Xuanwu Hospital of Capital Medical University (Registration number: CTR-IPR-20-11012). Written informed consent was obtained from all participants on the provision of a complete study description.
ORCID iD: Shuangling Xiu 
https://orcid.org/0000-0002-8549-4374
Contributor Information
Shuangling Xiu, Department of Endocrinology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China.
Qiuju Liao, Department of Rheumatology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China.
Lina Sun, Department of Endocrinology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, China.
Piu Chan, Department of Neurobiology, Geriatrics, and Neurology, Xuanwu Hospital, No. 45 Changchun St., Xicheng District, Beijing, China; Department of Neurology, Beijing Institute of Geriatrics, Xuanwu Hospital of Capital Medical University, Beijing, 100053, China; Parkinson’s Disease Center of Beijing Institute for Brain Disorders, Beijing 100053, China; Key Laboratory on Neurodegenerative Disease of Ministry of Education, Beijing 100053, China; Beijing Key Laboratory for Parkinson’s Disease, Beijing 100053, China; National Clinical Research Center for Geriatric Disorders, Beijing 100053, China.
References
- 1. Biessels GJ, Strachan MW, Visseren FL, et al. Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions. Lancet Diabetes Endocrinol 2014, 2: 246–255. [DOI] [PubMed] [Google Scholar]
- 2. Pal K, Mukadam N, Petersen I, et al. Mild cognitive impairment and progression to dementia in people with diabetes, prediabetes and metabolic syndrome: a systematic review and meta-analysis. Soc Psychiatry Psychiatr Epidemiol 2018; 53: 1149–1160. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Zilliox LA, Chadrasekaran K, Kwan JY, et al. Diabetes and cognitive impairment. Curr Diab Rep 2016; 16: 87. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Feinkohl I, Price JF, Strachan MW, et al. The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors. Alzheimers Res Ther 2015; 7: 46. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Ji L, Hu D, Pan C, et al. Primacy of the 3B approach to control risk factors for cardiovascular disease in type 2 diabetes patients. Am J Med 2013; 126: 925.e11–22. [DOI] [PubMed] [Google Scholar]
- 6. Cooper C, Sommerlad A, Lyketsos CG, et al. Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry 2015; 172: 323–334. [DOI] [PubMed] [Google Scholar]
- 7. Kloppenborg RP, van den Berg E, Kappelle LJ, et al. Diabetes and other vascular risk factors for dementia: which factor matters most? A systematic review. Eur J Pharmacol 2008; 585: 97–108. [DOI] [PubMed] [Google Scholar]
- 8. Umegaki H, Iimuro S, Shinozaki T, et al. Risk factors associated with cognitive decline in the elderly with type 2 diabetes: pooled logistic analysis of a 6-year observation in the Japanese elderly diabetes intervention trial. Geriatr Gerontol Int 2012; 12(Suppl. 1): 110–116. [DOI] [PubMed] [Google Scholar]
- 9. Xu W, Wang HF, Wan Y, et al. Leisure time physical activity and dementia risk: a dose-response meta-analysis of prospective studies. BMJ Open 2017; 7: e014706. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. Devore EE, Kang JH, Okereke O, et al. Physical activity levels and cognition in women with type 2 diabetes. Am J Epidemiol 2009; 170: 1040–1047. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Katon W, Pedersen HS, Ribe AR, et al. Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study. JAMA Psychiatry 2015; 72: 612–619. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Koekkoek PS, Rutten GE, Ruis C, et al. Mild depressive symptoms do not influence cognitive functioning in patients with type 2 diabetes. Psychoneuroendocrinology 2013; 38: 376–386. [DOI] [PubMed] [Google Scholar]
- 13. Feinkohl I, Keller M, Robertson CM, et al. Clinical and subclinical macrovascular disease as predictors of cognitive decline in older patients with type 2 diabetes: the Edinburgh type 2 Diabetes Study. Diabetes Care 2013; 2779–2786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Bruce DG, Davis WA, Casey GP, et al. Predictors of cognitive decline in older individuals with diabetes. Diabetes Care 2008; 2103–2107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Fei M, Yan Ping Z, Ru Juan M, et al. Risk factors for dementia with type 2 diabetes mellitus among elderly people in China. Age and Ageing 2013; 42: 398–400. [DOI] [PubMed] [Google Scholar]
- 16. Chhetri JK, Zheng Z, Xu X, et al. The prevalence and incidence of frailty in Pre-diabetic and diabetic community-dwelling older population: results from Beijing longitudinal study of aging II (BLSA-II). BMC Geriatr 2017; 17: 47. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Xiu S, Zheng Z, Guan S, et al. Serum uric acid and impaired cognitive function in community-dwelling elderly in Beijing. Neurosci Lett 2017; 637: 182–187. [DOI] [PubMed] [Google Scholar]
- 18. Wenham PR, Price WH, Blandell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991; 337: 1158–1159. [DOI] [PubMed] [Google Scholar]
- 19. Zhang MY, Katzman R, Salmon D, et al. The prevalence of dementia and Alzheimer’s disease in Shanghai, China: impact of age, gender, and education. Ann Neurol 1990; 27: 428–437. [DOI] [PubMed] [Google Scholar]
- 20. Burke WJ, Roccaforte WH, Wengel SP. The short form of the Geriatric Depression Scale: a comparison with the 30-item form. J Geriatr Psychiatry Neurol 1991; 4: 173–178. [DOI] [PubMed] [Google Scholar]
- 21. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539–553. [DOI] [PubMed] [Google Scholar]
- 22. Hong JY, Lan TY, Tang GJ, et al. Gout and the risk of dementia: a national wide population-based cohort study. Arthritis Res Ther 2015; 139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Zhou B, Cooperative Meta-analysis Group of China Obesity Task Force. Predictive values of body mass index and waist circumference to risk factors of related disease in Chinese adult population [in Chinese]. Zhonghua Liu Xing Bing Xue Za Zhi 2002; 23: 5–10. [PubMed] [Google Scholar]
- 24. Ganguli M, Fu B, Snitz BE, et al. Mild cognitive impairment: incidence and vascular risk factors in a population-based cohort. Neurology 2013; 80: 2112–2120. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. Bruce DG, Davis WA, Casey GP, et al. Predictors of cognitive impairment and dementia in older people with diabetes. Diabetologia 2008; 51: 241–248. [DOI] [PubMed] [Google Scholar]
- 26. Katon W, Lyles CR, Parker MM, et al. Association of depression with increased risk of dementia in patients with type 2 diabetes: the Diabetes and Aging Study. Arch Gen Psychiatry 2012; 69: 410–417. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Jorm AF. History of depression as a risk factor for dementia: an updated review. Aust N Z J Psychiatry 2001; 35: 776–781. [DOI] [PubMed] [Google Scholar]
- 28. Vinkers DJ, Gussekloo J, Stek ML, et al. Temporal relation between depression and cognitive impairment in old age: prospective population based study. BMJ 2004; 329: 881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Groot C, Hooghiemstra AM, Raijmakers PG, et al. The effect of physical activity on cognitive function in patients with dementia: a meta-analysis of randomized control trials. Ageing Res Rev 2016; 25: 13–23. [DOI] [PubMed] [Google Scholar]
- 30. Devenney KE, Sanders ML, Lawlor B, et al. ; NeuroExercise Study Group. The effects of an extensive exercise programme on the progression of Mild Cognitive Impairment (MCI): study protocol for a randomised controlled trial. BMC Geriatrics 2017; 17: 75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Sabia S, Dugravot A, Dartigues JF, et al. Physical activity, cognitive decline, and risk of dementia: 28 year follow-up of Whitehall II cohort study. BMJ 2017; 357: j2709. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Wang Y, Song M, Yu L, et al. Mild cognitive impairment: vascular risk factors in community elderly in four cities of Hebei Province, China. PloS One 2015; 10: e0124566. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Kennelly SP, Lawlor BA, Kenny RA. Blood pressure and the risk for dementia: a double edged sword. Ageing Res Rev 2009; 8: 61–70. [DOI] [PubMed] [Google Scholar]
- 34. McGuinness B, Todd S, Passmore P, et al. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009; CD004034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Anstey KJ, Cherbuin N, Budge M, et al. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. Obes Rev 2011; 15: e426–e437. [DOI] [PubMed] [Google Scholar]
- 36. Singh-Manoux A, Dugravot A, Shipley M, et al. Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study. Alzheimers Dement 2018; 14: 178–186. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Williamson JD, Launer LJ, Bryan RN, et al. Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial, JAMA Intern Med 2014; 174: 324–333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Van Vliet P. Cholesterol and late-life cognitive decline. J Alzheimers Dis 2012; 30(Suppl 2): S147–S162. [DOI] [PubMed] [Google Scholar]
- 39. Chen G, Cai L, Chen B, et al. Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment. Diabetes Care 2011; 34: 2586–2590. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Rusanen M, Kivipelto M, Quesenberry CP, Jr, et al. Heavy smoking in midlife and long-term risk of Alzheimer disease and vascular dementia. Arch Intern Med 2011; 171: 333–339. [DOI] [PubMed] [Google Scholar]
- 41. Zhong G, Wang Y, Zhang Y, et al. Smoking is associated with an increased risk of dementia: a meta-analysis of prospective cohort studies with investigation of potential effect modifiers. Plos One 2015; 10: e0118333. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Choi D, Choi S, Park SM. Effect of smoking cessation on the risk of dementia: a longitudinal study. Ann Clin Transl Neurol 2018; 5: 1192–1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Zhuang JP, Wang G, Cheng Q, et al. Cognitive impairment and the associated risk factors among the elderly in the Shanghai urban area: a pilot study from China. Transl Neurodegener 2012; 1: 22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Norton MC, Piercy KW, Rabins PV, et al. Caregiver-recipient closeness and symptom progression in Alzheimer disease. The Cache County Dementia Progression Study. J Gerontol B Psychol Sci Soc Sci 2009; 64: 560–568. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Wright LK. Alzheimer’s disease afflicted spouses who remain at home: can human dialectics explain the findings? Soc Sci Med 1994; 38: 1037–1046. [DOI] [PubMed] [Google Scholar]
- 46. Jia J, Wang F, Wei C, et al. The prevalence of dementia in urban and rural areas of China. Alzheimers Dement 2014; 10: 1–9. [DOI] [PubMed] [Google Scholar]
- 47. Tang HD, Zhou Y, Gao X, et al. Prevalence and risk factor of cognitive impairment were different between urban and rural population: a community-based study. J Alzheimers Dis 2016; 49: 917–925. [DOI] [PubMed] [Google Scholar]
- 48. Rohn TT. Is apolipoprotein E4 an important risk factor for vascular dementia? Int J Clin Exp Pathol 2014; 7: 3504–3511. [PMC free article] [PubMed] [Google Scholar]
- 49. Giau VV, Bagyinszky E, An SS, et al. Role of apolipoprotein E in neurodegenerative diseases. Neuropsychiatr Dis Treat 2015; 11: 1723–1737. [DOI] [PMC free article] [PubMed] [Google Scholar]